MedAI Verdict
Decision support

Clinical Decision Support

KATE logo

KATE

by Mednition  ·  founded 2014  ·  US

Last verified

KATE AI recommends emergency department triage acuity and flags sepsis risk from EHR data at triage.

Visit KATE (opens in new tab)Read our methodology

At a glance

Pricing
No public price.
HIPAA
Not disclosed
SOC 2
Not disclosed
EHRs
—
Founded
2014
HQ
US
On this page

Independent score  ·  By our public rubric

12/100Tracked

Not rated: too little independent evidence yet.

How it’s computed →
  • Regulatory & Compliance
    0/22

    No FDA clearance listed

  • Clinical Integration
    0/11.6

    No EHR integrations listed

  • Evidence Strength
    0/30

    No peer-reviewed coverage

  • Vendor & Market
    9/18

    Founded 2014 (12 years)

  • Sentiment & Transparency
    1.3/2.5

    Pricing on request, no public amounts

▸ Show all 11 dimensions

Regulatory & Compliance

  • FDA clearance0/12

    No FDA clearance listed

  • HIPAA / SOC2 / BAA0/10

    No public HIPAA/SOC2/BAA attestation

Clinical Integration

  • EHR integrations (count)0/6

    No EHR integrations listed

  • Top-3 EHR coverage (Epic / Oracle / Athena)0/5

    None of the top-3 EHRs covered

  • Bidirectional write-back0/1

    No bidirectional write-back documented

Evidence Strength

  • Peer-reviewed papers0/21

    No peer-reviewed coverage

  • RCT / meta-analysis / systematic review0/9

    No RCT, meta-analysis, or systematic review

Vendor & Market

  • Funding & adoption signal3/12

    Seed-stage or unfunded

  • Years in market6/6

    Founded 2014 (12 years)

Sentiment & Transparency

  • Pricing transparency1/3

    Pricing on request, no public amounts

Scored November 2, 2026 · Public scoring method v1.2.0

KATE AI recommends emergency department triage acuity and flags sepsis risk from EHR data at triage.

No public price.

Evidence record

FDA decisions

No FDA decision cited in our research as of November 2, 2026.

Verification
  • Score computed November 2, 2026, method 1.2.0
  • Review written November 2, 2026
Cite this record

MedAI Verdict, KATE record, https://medaiverdict.com/tools/mednition, version November 2, 2026

Change history
View every change to this record

Bottom line

Mednition, Inc. of Burlingame, California, sells KATE, which it describes as real-time AI at emergency department triage that recommends an acuity level and flags sepsis risk from EHR data. The FDA granted KATE Sepsis a Breakthrough Device Designation on November 14, 2023, which is a designation and not a clearance, and the 510(k) database has no Mednition record. Adventist Health White Memorial and Adventist Health Glendale are the named customers. It fits an ED looking at triage decision support from a vendor with named hospital customers, and a hospital that requires cleared sepsis software has no clearance to cite for KATE.

What does the vendor say KATE does?

Mednition calls KATE "a real-time, AI-powered risk intelligence platform at triage" that helps nurses "spot high-risk patients faster and far more accurately with zero workflow changes." The product line is KATE AI Triage, KATE Sepsis and a Clinical Data Engine. The 2019 launch release called KATE "the first real-time decision support solution designed specifically to help emergency nurses." The homepage says it fits "your existing workflow and EMR" and names no EHR, and it does not state CE or UKCA status.

What accuracy figures does the vendor report?

The 2019 release claimed triage accuracy rose 26.9% overall and 93.2% for high-acuity patients at Adventist Health White Memorial, with the study then "in peer review." A November 2023 announcement on KATE Sepsis claimed sensitivity up to 118% better than standard screening for septic shock and specificity of 95%. A testimonial from White Memorial sits on the homepage.

Which papers carry Mednition authors?

Three PubMed papers have Mednition employees among the authors: PMID 41973937 (Prehospital Emergency Care, 2026, machine learning models for sepsis and stroke detection from EMS data), PMID 39904169 (International Emergency Nursing, 2025, pre-eclampsia identification at ED triage) and PMID 37782846 (Journal of Nursing Care Quality, 2024, triage accuracy and core measures compliance for heart attack and heart failure in older adults). None is confirmed as a study of KATE.

Company and price

Mednition was founded in 2014, and older papers give a San Mateo address. A $10 million Series A led by Concord Health Partners was announced in 2019, and Tracxn lists it as the only round. The homepage gives two visit figures, a banner of over 5,000,000 patient visits and a counter at 3,990,601 ED visits. The price is not public.

The verdict

An ED that wants triage decision support and can accept accuracy gains reported by the vendor is the buyer KATE describes. A designation is not a clearance, so sepsis alerts that must come from cleared software are not covered by KATE Sepsis today.

Editorial review last generated November 2, 2026. Synthesized from clinician sentiment, peer-reviewed coverage, and our editorial silo picks. Refined by hand where vendor facts change.

What it costs

All tiers are custom-quoted. The vendor does not publish per-provider list pricing.

TierMonthlyAnnualNotes
EnterpriseNot statedNot statedNo public price.

Source: vendor pricing page. Last checked November 2, 2026.

Who builds it

KATE (Mednition) was founded in 2014 in US, putting it 12 years into market.

Other decision support

See the full decision support ranking